http://www.xconomy.com/san-diego/2009/07/02/sequenom-discloses-sec-probe-how-evoke-pharma-got-its-drug-illumina-sales-fall-short-more-san-diego-life-sciences-news/ Business + Technology in the Exponential Economy Sun, 22 Nov 2009 19:43:29 -0600 http://wordpress.org/?v=2.8.6 hourly 1 http://www.xconomy.com/san-diego/2009/07/02/sequenom-discloses-sec-probe-how-evoke-pharma-got-its-drug-illumina-sales-fall-short-more-san-diego-life-sciences-news/comment-page-1/#comment-68534 M Keanes Thu, 02 Jul 2009 21:03:27 +0000 http://www.xconomy.com/?p=31701#comment-68534 Interesting that one of Evoke's founders was on the board of Somaxon Pharmaceuticals which just so happened to have had a drug for tardive dyskinesia (the key side effect for metoclopramide) that they let go. Maybe there's a connection here? Interesting that one of Evoke’s founders was on the board of Somaxon Pharmaceuticals which just so happened to have had a drug for tardive dyskinesia (the key side effect for metoclopramide) that they let go. Maybe there’s a connection here?

]]>